Graticule Asia Macro Advisors’s Vera Therapeutics VERA Stock Holding History

Graticule Asia Macro Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2K	Buy	+260	New	+$9.69K	﹤0.01%	200

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Graticule Asia Macro Advisors's VERA Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Vera Therapeutics (VERA) in Q2 2026: 260 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #200 among its holdings.

219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Graticule Asia Macro Advisors held 260 shares of Vera Therapeutics worth $11.2K as of Q2 2026.
Vera Therapeutics was a new Graticule Asia Macro Advisors position in Q2 2026.
Vera Therapeutics made up ﹤0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #200 holding.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.